China New Product Influenza A Virus, Influenza B Virus, Adenovirus, Mycoplasma Pneumoniae - Macro & Micro-Test Sample Release Reagent – Macro & Micro-Test
China New Product Influenza A Virus, Influenza B Virus, Adenovirus, Mycoplasma Pneumoniae - Macro & Micro-Test Sample Release Reagent – Macro & Micro-Test Detail:
Product name
Macro & Micro-Test Sample Release Reagent
Certificate
CE, FDA, NMPA
Features
Rapid: only 5 mins.
Easy: only 3 steps (1.add the sample 2.Mix upside and down 10 times 3. Leave it for 5 mins).
Main components
| Name | Main components | Component specifications | Quantity |
| Sample Release reagent | Dithiothreitol, sodium dodecyl sulfate (SDS), RNase inhibitor, surfactant, purified water | 0.5mL/Vial | 50 Vial |
Note: Components in different batches of kits are not interchangeable.
Storage conditions and shelf life
Store and transport at room temperature. The shelf life is 24 months.
Applicable instruments
Instruments and equipment during sample processing, such as pipettes, vortex mixers, water baths, etc.
Sample requirements
Freshly collected oropharyngeal swabs, nasopharyngeal swabs.
Precision
When this kit is used for extraction from the in-house precision reference CV for 10 replicates, the coefficient of variation (CV, %) of Ct value is not more than 10%.
Inter-batch difference
When the in-house precision reference is tested on three batches of kits under trial production upon repeated extraction and, the coefficient of variation (CV, %) of Ct value is not more than 10%.
Performance comparison
● Extraction efficiency comparsion
|
Efficiency comparsion of magnetic beads method and sample releaser |
||||
|
concentration |
magnetic beads method |
sample releaser |
||
|
orfab |
N |
orfab |
N |
|
|
20000 |
28.01 |
28.76 |
28.6 |
29.15 |
|
2000 |
31.53 |
31.9 |
32.35 |
32.37 |
|
500 |
33.8 |
34 |
35.25 |
35.9 |
|
200 |
35.25 |
35.9 |
35.83 |
35.96 |
|
100 |
36.99 |
37.7 |
38.13 |
undet |
The extraction efficiency of sample releaser was similar to that of magnetic beads method, and the concentration of pathogen could be 200Copies/mL.
● CV value comparison
|
Repeatability of sample releaser extraction |
||
| concentration:5000Copies/mL |
ORF1ab |
N |
|
30.17 |
30.38 |
|
|
30.09 |
30.36 |
|
|
30.36 |
30.26 |
|
|
30.03 |
30.48 |
|
|
30.14 |
30.45 |
|
|
30.31 |
30.16 |
|
|
30.38 |
30.7 |
|
|
30.72 |
30.79 |
|
| CV |
0.73% |
0.69% |
When tested at 5,000 copies /mL, the CV of orFab and N was 0.73% and 0.69%, respectively.
Product detail pictures:
Related Product Guide:
Our products are broadly identified and trustworthy by people and may meet continually modifying financial and social requires of China New Product Influenza A Virus, Influenza B Virus, Adenovirus, Mycoplasma Pneumoniae - Macro & Micro-Test Sample Release Reagent – Macro & Micro-Test , The product will supply to all over the world, such as: Portugal, Croatia, Tunisia, Welcome to visit our company, factory and our showroom where displays various products that will meet your expectation. Meanwhile, it is convenient to visit our website, and our sales staff will try their best to provide you the best service. Please contact us if you need more information. Our aim is to help customers realize their goals. We are making great efforts to achieve this win-win situation.
By Sahid Ruvalcaba from Latvia - 2018.10.01 14:14
High production efficiency and good product quality, fast delivery and completed after-sale protection, a right choice, a best choice.
By Danny from Albania - 2017.09.29 11:19
